BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:41 am Sale |
2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-990,000 (Position Closed) |
Filing |
| 2023-02-06 4:43 pm Purchase |
2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR |
BIOTECHNOLOGY VALUE FUND L P | 990,000 9.100% |
990,000 (New Position) |
Filing |